|
Garcia-Torralba E, Garcia-Lorenzo E, Doger B, Spada F, Lamarca A. Immunotherapy in Neuroendocrine Neoplasms: A Diamond to Cut. Cancers (Basel). 2024 Jul 13;16(14):2530. doi: 10.3390/cancers16142530. PubMed PMID: 39061170; PubMed Central PMCID: PMC11275146.
AÑO: 2024; IF: 4.5
|
39061170
|
Garcia-Torralba E, Galluzzi L, Buque A. Prognostic value of atypical B cells in breast cancer. Trends Cancer. 2024 Nov;10(11):990-991. doi: 10.1016/j.trecan.2024.09.009. Epub 2024 Oct 1. PubMed PMID: 39353814.
AÑO: 2024; IF: 14.3
|
|
Sanchez Canovas M, Garcia Torralba E, Blaya Boluda N, Sanchez Saura A, Puche Palao G, Sanchez Fuentes A, Martinez Montesinos L, Poveda Ganga C, Garcia Tomas L, Bayona Jimenez J, Cos Zapata A, Munoz Jurado CM, Pina Mingorance I, Caravaca Hernandez MA, Vicente Garcia V, Ayala de la Pena F. Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance? Clin Transl Oncol. 2024 Dec;26(12):3226-3235. doi: 10.1007/s12094-024-03548-8. Epub 2024 Jun 12. PubMed PMID: 38865035.
AÑO: 2024; IF: 2.8
|
|
Cruz-Castellanos P, Gil-Raga M, Jimenez-Fonseca P, Ghanem I, Hernandez R, Piera-Molons N, Cano JM, Gallego-Martinez A, Garcia-Torralba E, Calderon C. Uncertainty and hope in relation to anxiety and depression in advanced lung cancer. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e847-e850. doi: 10.1136/spcare-2022-003882. PubMed PMID: 36100428.
AÑO: 2024; IF: 2.0
|
|
Garcia-Torralba E, Navarro Manzano E, Luengo-Gil G, De la Morena Barrio P, Chaves Benito A, Perez-Ramos M, Alvarez-Abril B, Ivars Rubio A, Garcia-Garre E, Ayala de la Pena F, Garcia-Martinez E. A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients. Front Oncol. 2023 May 29;13:1182725. doi: 10.3389/fonc.2023.1182725. eCollection 2023. PubMed PMID: 37313470; PubMed Central PMCID: PMC10258327.
AÑO: 2023; IF: 3.5
|